证券日报网讯1月20日，普莱柯（603566）发布公告称，公司预计2025年年度实现归属于母公司所有者 的净利润为17，600.00万元到19，500.00万元，同比上升89.64%到110.11%；实现归属于母公司所有者 的扣除非经常性损益的净利润为13，700.00万元到15，300.00万元，同比上升70.19%到90.07%。 ...

Corporate Announcements - Vanke A announced that bondholders of "21 Vanke 02" can choose to sell back their bonds to the company at a price of 100 yuan per bond during the redemption period from December 9 to December 15, 2025, with a total of 10.32 million bonds eligible for redemption [2] - Kangxin New Materials plans to acquire 51% of Wuxi Yubang Semiconductor for 392 million yuan, aiming to transform and upgrade its business towards the semiconductor industry [3] - Lio Co. has completed its stock suspension review and will resume trading on January 21, 2026, with no significant changes in its business operations [4] - ST Saiwei is at risk of being delisted due to an expected negative net asset value at the end of 2025 [5] - Kailong High-Tech is planning to acquire control of Shenzhen Jinwangda Electromechanical Co., with stock suspension effective from January 21, 2026 [6] - Guangdong Hongtu plans to invest up to 95 million yuan to establish a wholly-owned subsidiary in Thailand for automotive parts production [7] - Debon Holdings intends to voluntarily withdraw its A-shares from the Shanghai Stock Exchange, with trading suspension starting January 21, 2026 [8] - Zangzi Island received an administrative regulatory decision due to failure to disclose financial support issues, leading to a warning for its chairman and secretary [9] - Qizheng Tibetan Medicine's "Ten Flavor Longdan Flower Capsules" has been approved as a second-level protected traditional Chinese medicine, enhancing its market competitiveness [10] Performance Forecasts - Longzi Co. expects a net profit of 900 million to 1.05 billion yuan for 2025, representing a year-on-year increase of 245.25% to 302.80% [12] - Tonghuashun forecasts a net profit of 2.735 billion to 3.282 billion yuan for 2025, an increase of 50% to 80% year-on-year [13] - Pulai Ke anticipates a net profit of 176 million to 195 million yuan for 2025, up 89.64% to 110.11% year-on-year [14] - Zhongfu Industrial expects a net profit of 1.55 billion to 1.7 billion yuan for 2025, an increase of 120.27% to 141.59% year-on-year [15] - Putailai forecasts a net profit of 2.3 billion to 2.4 billion yuan for 2025, an increase of 93.18% to 101.58% year-on-year [17] - Tongfu Microelectronics expects a net profit of 1.1 billion to 1.35 billion yuan for 2025, an increase of 62.34% to 99.24% year-on-year [18] - Hikvision reported a net profit of 14.188 billion yuan for 2025, a year-on-year increase of 18.46% [19] - Bright Dairy anticipates a net loss of 120 million to 180 million yuan for 2025, compared to a profit of 722 million yuan in the previous year [20] - Aerospace Changfeng expects a net loss of 170 million to 200 million yuan for 2025, with a reduction in losses compared to the previous year [21] - Guosheng Technology forecasts a net loss of 325 million to 650 million yuan for 2025, impacted by low component prices in the photovoltaic industry [22] Share Buybacks - Haier Smart Home plans to repurchase up to 2 million euros or a maximum of 1 million shares of its D-shares, which will be canceled to reduce registered capital [24] Major Contracts - Anhui Construction announced winning two projects with total contract values of 562 million yuan and 814 million yuan, respectively [26] - Guodun Quantum plans to sign a technology implementation license contract with the University of Science and Technology of China, involving multiple patents and proprietary technologies [27] - Huadian Technology signed a contract worth approximately 374 million yuan for wind power tower procurement related to a hydrogen production project [28] - Huaqin Technology signed sales contracts totaling 328 million yuan for special functional materials used in aircraft engines [29]

Group 1 - Zhongshi Technology expects a net profit of 330 million to 370 million yuan for 2025, representing a year-on-year growth of 63.86% to 83.73% [1] - Yuegui Co. anticipates a net profit of 443 million to 503 million yuan for 2025, with a year-on-year increase of 59.03% to 80.57% [3] - Zhaoyan Pharmaceutical forecasts a net profit of 233 million to 349 million yuan for 2025, indicating a growth of 214% to 371% compared to the previous year [4] - Su Shi Testing predicts a net profit of 245 million to 265 million yuan for 2025, reflecting a year-on-year increase of 6.8% to 15.51% [5] - Zhongfu Industrial expects a net profit of 1.55 billion to 1.7 billion yuan for 2025, with an increase of 120.27% to 141.59% year-on-year [23] - Putailei anticipates a net profit of 2.3 billion to 2.4 billion yuan for 2025, representing a growth of 93.18% to 101.58% [16] - Qiaoyuan Co. expects a net profit of 226 million to 256 million yuan for 2025, indicating a year-on-year increase of 51.51% to 71.62% [17] - Hikvision forecasts a net profit of 14.188 billion yuan for 2025, with a year-on-year growth of 18.46% [18] - Huacheng Equipment predicts a net profit of 182 million to 212 million yuan for 2025, reflecting a growth of 193.64% to 242.04% [26] - Longhua Chemical expects a net profit of 89.41 million to 109 million yuan for 2025, with a year-on-year increase of 53.75% to 87.91% [27] - Xinyuan Biotech anticipates a net profit of 100 million to 130 million yuan for 2025, compared to a loss of 47.57 million yuan in the previous year [24] - Dongwei Technology forecasts a net profit of 120 million to 140 million yuan for 2025, indicating a growth of 73.23% to 102.10% [34] - Chip Microelectronics expects a net profit of 275 million to 295 million yuan for 2025, reflecting a year-on-year increase of 71.13% to 83.58% [41] Group 2 - Huangshan Tourism's subsidiary plans to invest approximately 133 million yuan in an upgrade project for the electric system of the Huangshan Taiping cableway, with a payback period of 4.38 years [2] - Nanjing Julong intends to invest 110 million yuan to establish a production line for modified plastics with an annual capacity of 60,000 tons [8] - Yongxing Materials has completed the commissioning of its lithium extraction project and achieved full production capacity [9] - Hengtong Co. plans to repurchase shares worth 80 million to 100 million yuan at a price not exceeding 14.5 yuan per share [12] - Fuxing Pharmaceutical's subsidiary received approval for clinical trials of a new drug for treating advanced colorectal cancer [13] - New Industry's syphilis antibody test kit has received IVDR CE certification [14] - Youxun Technology has established a wholly-owned subsidiary in Brazil with an investment of 10 million reais [15] - Guangdong Hongtu plans to invest up to 95 million yuan to establish a subsidiary in Thailand for automotive parts production [33]

Core Insights - The pet economy in China is rapidly expanding, with the market expected to exceed 811.4 billion yuan by 2025, and the urban pet population reaching 120 million [2][6]. Group 1: Industry Overview - The pet economy has evolved from mere companionship to a lifestyle, creating a vast ecosystem around the entire lifecycle of pets [5][6]. - The geographical distribution and specialization within the pet industry have developed into a national framework, with significant contributions from various regions [6][7]. Group 2: Regional Highlights - Liaoning Anshan is emerging as a major hub for pet breeding, supplying over 60% of the national pet dog and cat population, with an industry scale exceeding 10 billion yuan [18][19][20]. - Hebei and Shandong are recognized as the primary pet food production areas, with a projected 14% increase in pet food shipment volume by 2025 [30][31]. - The Yangtze River Delta is positioned as the "universe center" for pet supplies, leveraging its supply chain advantages and manufacturing capabilities [49][50]. Group 3: Emerging Trends - The pet vaccine sector is witnessing significant growth, with companies like Princely and Jinhe Bio reporting substantial revenue increases, indicating a burgeoning market for pet health products [78][86]. - The smart pet products market is projected to surpass 10.2 billion yuan, driven by advancements in AI and e-commerce integration [91][92]. - The "pet+" trend is gaining traction, with services like pet transportation and photography experiencing exponential growth, reflecting a shift towards emotional spending in pet ownership [106][108]. Group 4: Infrastructure and Services - Guangzhou Baiyun Airport has become the first pet-friendly airport in China, facilitating easier travel for pet owners [120][129]. - The development of pet-friendly cities and services is on the rise, enhancing the overall experience for pet owners and their pets [116][118].

证券之星消息，1月20日动物保健板块较上一交易日下跌0.01%，生物股份领跌。当日上证指数报收于 4113.65，下跌0.01%。深证成指报收于14155.63，下跌0.97%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300871 | 回盛生物 | 31.49 | 11.83% | 38.34万 | | 11.69 乙 | | 603566 | 普莱柯 | 13.36 | 1.06% | 5.21万 | | 6961.35万 | | 300119 | 瑞普生物 | 20.55 | 0.98% | 1 6.64万 | | 1.36亿 | | 920275 | 驱动力 | 9.35 | 0.75% | 2.23万 | | 2072.97万 | | 600195 | 中牧股份 | 8.54 | 0.59% | 38.73万 | | 3.32亿 | | 603718 | 海利生物 | 6.46 | 0.00% | 7.53万 | | 4860.40万 ...

每经AI快讯，普莱柯1月20日晚间发布业绩预告，预计2025年年度实现归属于母公司所有者的净利润为 1.76亿元~1.95亿元，与上年同期相比，增加8319.35万元~1.02亿元，同比上升89.64%~110.11%。业绩变 动主要原因是，报告期，禽腺病毒系列联苗等新产品上市为公司贡献了新的业绩增长点，宠物板块通过 持续发力渠道搭建和品牌打造进而取得了快速发展。2025年，面对行业竞争加剧、价格承压以及下游养 殖行情波动等不利因素，公司聚焦营销体系变革，加强销售费用管控，同时优化生产工艺和采购管理， 进一步降低生产成本，整体展现了较强的经营韧性，实现了高质量、高效益发展的经营目标。 （记者 曾健辉） 每经头条（nbdtoutiao）——"一周干完一年的活"，一款AI编程工具让硅谷程序员集体"上瘾"！科技公 司CEO：一辈子钻研的技能被它一次性解决，让人兴奋又恐惧 ...

人民财讯1月20日电，普莱柯（603566）1月20日公告，预计2025年年度实现归属于母公司所有者的净利 润为1.76亿元到1.95亿元，同比上升89.64%到110.11%。报告期，禽腺病毒系列联苗等新产品上市为公 司贡献了新的业绩增长点，宠物板块通过持续发力渠道搭建和品牌打造进而取得了快速发展。 ...

普莱柯（603566）(603566.SH)披露2025年年度业绩预告，公司预计2025年年度实现归属于母公司所有 者的净利润为1.76亿元到1.95亿元，同比上升89.64%到110.11%;实现归属于母公司所有者的扣除非经常 性损益的净利润为1.37亿元到1.53亿元，同比上升70.19%到90.07%。 报告期，禽腺病毒系列联苗等新产品上市为公司贡献了新的业绩增长点，宠物板块通过持续发力渠道搭 建和品牌打造进而取得了快速发展。 ...

证券代码：603566 证券简称：普莱柯 公告编号：2026-004 普莱柯生物工程股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要提示： 一、本期业绩预告情况 （一）本期业绩预告期间 三、本期业绩预增的主要原因 2025 年 1 月 1 日至 2025 年 12 月 31 日 （二）业绩预告具体情况 1、经公司财务部门初步测算，预计 2025 年年度实现归属于母公司所有者的 净利润为 17,600.00 万元到 19,500.00 万元，与上年同期相比，增加 8,319.35 万元 到 10,219.35 万元，同比上升 89.64%到 110.11%。 预计 2025 年年度实现归属于母公司所有者的扣除非经常性损益的净利润为 13,700.00 万元到 15,300.00 万元，与上年同期相比，增加 5,650.30 万元到 7,250.30 万元，同比上升 70.19%到 90.07%。 2、本次业绩预告为公司初步测算数据，未经审计。 二、上年同期经营业绩和财务状况 （一）归属 ...

智通财经APP讯，普莱柯(603566.SH)披露2025年年度业绩预告，公司预计2025年年度实现归属于母公 司所有者的净利润为1.76亿元到1.95亿元，同比上升89.64%到110.11%;实现归属于母公司所有者的扣除 非经常性损益的净利润为1.37亿元到1.53亿元，同比上升70.19%到90.07%。 报告期，禽腺病毒系列联苗等新产品上市为公司贡献了新的业绩增长点，宠物板块通过持续发力渠道搭 建和品牌打造进而取得了快速发展。 ...